BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
Clinical trial NCT03502577 · TERMINATED
Trial details
- NCT number
- NCT03502577
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2022-04-20
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.